Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 15 August 2017, 19:00 HKT/SGT
Share:
    

Source: Singapore eDevelopment Ltd
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases

SINGAPORE, Aug 15, 2017 - (ACN Newswire) - Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications.

3F (Functional Fragrance Formulation) is a suite of functional fragrances being developed. The first product, 3F Mosquito, is made of specialised oils sourced from botanicals which mosquitoes avoid. 3F Mosquito was designed with an objective to identify, then create a suitable formula that was pleasant, yet excels in providing layers of protection against mosquitoes.

Daryl Thompson, Global BioLife Director of Scientific Initiatives, leads the 3F research. "The specialised oils in 3F Mosquito are scientifically proven to affect a mosquito's receptors, essentially making the mosquito blind to your presence," says Thompson.

In addition to 3F Mosquito, Global BioLife and Chemia are developing fragrances as additives for use in laundry detergents, shampoos and lotions, providing additional layers of protection against mosquitoes, and developing advanced coatings for industrial and medical applications.

"Biomedical science has become increasingly vital. Global BioLife is taking steps toward providing solutions to issues that have plagued the biomedical field for decades. This working collaboration marks a first steps in actively changing the game of healthcare," said Chan Heng Fai, SeD Executive Chairman and Chief Executive Officer, and a Global BioLife Director.

Global BioLife is an 80%-held subsidiary of SeD wholly-owned Global BioMedical Inc. The remaining shareholding in Global BioLife is held by Thompson's GRDG Sciences LLC and Australia Securities Exchange-listed Holista CollTech Limited, in equal proportions of 10% each.

About Chemia Corporation
Chemia Corporation provides high quality, cost effective fragrances to the manufacturers of personal care, household and industrial & institutional products. Thomas A. Meyer is the Vice-President of Innovation and Sustainability. For further information, please visit www.chemiacorp.com.

About GRDG Sciences LLC
GRDG Sciences LLC is a natural products discovery drug research company incorporated in Florida, USA. The Company was set up by natural products scientist Daryl Thompson. Thompson is a biochemist, nominated for the Nobel Prize in 2015 and 2016 for his research in pandemic technology.

About Holista CollTech Ltd
Holista CollTech is incorporated in Australia and listed on the Australian Securities Exchange. A research-driven biotechnology company, Holista focuses on research and development of product in the natural products space. Founder and Chief Executive Officer Dr Rajen Manicka holds a PhD in Holistic Medicine and a Masters of Business Administration. For further information, please visit www.holistaco.com.

About Singapore eDevelopment Ltd

Singapore eDevelopment Ltd (SeD) was incorporated on 9 Sept 2009, and listed by SGX Catalist (SGX:SGE) in July 2010. SeD is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg.

Issued for the Company:
WeR1 Consultants Pte Ltd
Ian Lau
Tel : +65 6737 4844
Email: ianlau@wer1.net



Aug 15, 2017 19:00 HKT/SGT
Topic: General Announcement
Sectors: HealthCare, Alternatives, Cosmetics/Spec.Chem
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Singapore eDevelopment Ltd
Nov 7, 2018 19:00 HKT/SGT
Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
June 18, 2018 19:00 HKT/SGT
Singapore eDevelopment Announces Corporate and Business Update
May 31, 2018 18:00 HKT/SGT
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
Mar 1, 2018 14:00 HKT/SGT
Singapore eDevelopment (SGX:40V) biomedical subsidiary confirms LB2 efficacy against Ebola
Nov 1, 2017 18:00 HKT/SGT
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
Oct 24, 2017 18:00 HKT/SGT
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
June 15, 2017 10:15 HKT/SGT
First-Year Performance of Global Systematic Multi-Strategy Fund
May 22, 2017 11:00 HKT/SGT
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
More news >>
 News Alerts
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: